首页|阿奇霉素对脂多糖诱导肺泡上皮细胞炎症损伤的作用及机制研究

阿奇霉素对脂多糖诱导肺泡上皮细胞炎症损伤的作用及机制研究

扫码查看
为了探究阿奇霉素对脂多糖(LPS)诱导的人肺泡上皮细胞增殖、凋亡及Janus激酶2(JAK2)/信号转导和转录启动因子3(STAT3)通路的调控作用,体外培养人肺泡上皮细胞A549,分为空白组(不做干预)、LPS组(10 μg/mL LPS处理24 h)、低/中/高浓度试验组(10 μg/mL LPS+1、2、4 μg/mL阿奇霉素)、阿奇霉素组(10 μg/mL LPS+4 μg/mL阿奇霉素)、抑制剂组(10 μg/mL LPS+50 μmol/L JAK2/STAT3通路抑制剂AG490)、阿奇霉素+抑制剂组(10 μg/mL LPS+4 μg/mL阿奇霉素+50 μmol/L AG490)、阿奇霉素+激活剂组(10 μg/mL LPS+4 μg/mL阿奇霉素+0.5 μmol/L JAK2/STAT3通路激活剂Colivelin).干预24 h后,采用酶联免疫吸附试验(ELISA)、细胞计数试剂盒-8(CCK-8)、5-乙炔基-2'脱氧尿嘧啶核苷(EdU)、Hoechst 33258染色法、蛋白免疫印迹法检测炎症因子白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)的表达水平、细胞活力、增殖率、凋亡率、半胱氨酸天冬氨酸蛋白酶-3(Caspase-3)、细胞周期素D1(Cyclin D1)及JAK2/STAT3信号通路相关蛋白表达水平.结果显示:LPS组细胞炎症因子IL-6、IL-8和TNF-α表达水平高于空白组,细胞活力低于空白组;与LPS组相比,高浓度试验组炎症因子IL-6、IL-8、TNF-α表达水平显著降低,细胞活力显著升高.选择在LPS组基础上有差异的4 μg/mL阿奇霉素作为阿奇霉素组进行后续试验.LPS组细胞增殖率、Cyclin D1蛋白表达水平低于空白组,细胞凋亡率、Caspase-3、p-JAK2、p-STAT3蛋白表达水平高于空白组.阿奇霉素组和抑制剂组显著扭转了LPS组上述指标的变化.与阿奇霉素组相比,阿奇霉素+抑制剂组细胞增殖率、Cyclin D1蛋白表达水平进一步显著升高,细胞凋亡率、IL-6、IL-8、TNF-α、Caspase-3、p-JAK2、p-STAT3蛋白表达水平进一步显著降低,阿奇霉素+激活剂组则显著逆转了上述指标的变化.本研究表明,阿奇霉素可通过抑制JAK2/STAT3信号通路减轻LPS诱导的A549细胞炎症损伤,促进细胞增殖并抑制凋亡.
Effect and Mechanism of Azithromycin on Inflammatory Injury of Alveolar Epithelial Cells Induced by Lipopolysaccharide
To explore the regulatory effects of azithromycin on lipopolysaccharide(LPS)-induced proliferation,apoptosis and Janus kinase 2(JAK2)/signal transduction and transcription promoter 3(STAT3)signaling pathways in human alveolar epithelial cells,in vitro culture of human alveolar epithelial cells A549,were divided into blank group(no intervention),LPS group(10 μg/mL LPS treated for 24 h),low/medium/high concentration experimental group(10 μg/mL LPS+1,2,4 μg/mL azithromycin)and azithromycin group(10 μg/mL LPS+4 μg/mL azithromycin),inhibitor group(10 μg/mL LPS+50 μmol/L JAK2/STAT3 pathway inhibitor AG490),azithromycin+inhibitor group(10 μg/mL LPS+4 μg/mL azithromycin+50 μmol/L AG490)and azithromycin+activator group(10 μg/mL LPS+4 μg/mL azithromycin+0.5 μmol/L JAK2/STAT3 pathway acti-vator Colivelin).After 24 hours of intervention,enzyme-linked immunosorption assay(ELISA),cell counting kit-8(CCK-8),5-acetyney-2'deoxyuracil nucleoside(EdU),Hoechst 33258 staining and Western blotting(WB)were used for the expression levels of inflammatory factors interleukin-6(IL-6),interleukin-8(IL-8),tumor necrosis factor-α(TNF-α),cell viability,prolif-eration rate,apoptosis rate,Caspase-3 and Cyclin D1 and the expression levels of JAK2/STAT3 signaling pathway related pro-teins.The results show that:compared with blank group,the expression levels of inflammatory cytokines IL-6,IL-8 and TNF-α in LPS group significantly increased,and cell viability significantly decreased.Compared with LPS group,the expression levels of inflammatory cytokines IL-6,IL-8 and TNF-α in high-concentration experimental group significantly decreased,and cell vi-ability significantly increased.In this study,4 μg/mL azithromycin with significant difference from LPS group was selected as azithromycin group for follow-up experiments.Compared with blank group,the cell proliferation rate and Cyclin D1 protein ex-pression levels in LPS group significantly decreased,while the apoptosis rate,Caspase-3,p-JAK2 and p-STAT3 protein expres-sion levels significantly increased.Compared with LPS group,azithromycin group and inhibitor group significantly reversed the changes of the above indexes.Compared with azithromycin group,cell proliferation rate and Cyclin D1 protein expression lev-els in azithromycin+inhibitor group further significantly increased,while apoptosis rate,IL-6,IL-8,TNF-α,Caspase-3,p-JAK2 and p-STAT3 protein expression levels further significantly decreased.Azithromycin+activator group significantly reversed the changes of the above indexes.Azithromycin can reduce LPS-induced inflammatory damage of A549 cells by inhibiting JAK2/STAT3 signaling pathway,promote cell proliferation and inhibit apoptosis,and provide evidence for exploring azithromycin treatment of LPS induced acute lung injury.

azithromycinJanus kinase 2signal transduction and transcription promoter 3alveolar epithelial cellsinflam-matory lung injury

温玲、李宝琪、赵艳敏、郑舒扬、苏颖

展开 >

秦皇岛市第一医院 儿科ICU,秦皇岛 066000

秦皇岛市第一医院 药学部,秦皇岛 066000

阿奇霉素 Janus激酶2 信号转导和转录启动因子3 肺泡上皮细胞 炎症性肺损伤

秦皇岛市科学技术研究与发展计划(2023)

202301A102

2024

激光生物学报
中国遗传学会

激光生物学报

CSTPCD
影响因子:0.378
ISSN:1007-7146
年,卷(期):2024.33(3)